21.09.2015 11:56:00

Pandox AB (publ) appoints new head of Investor Relations

Regulatory News:

Camilla Weiner has been appointed as new head of Investor Relations at Pandox, starting 21 September 2015. Camilla replaces Thomas Backteman as Head of Investor Relations, forms part of Pandox’s Executive Management group and reports to the company’s CFO Liia Nõu.

Camilla Weiner has long experience from leading positions in investor relations and communications, including Director Corporate Communications and member of the Senior Executive Team at SCA AB, as well as Director Corporate Communications and member of Group Executive Management at Axfood AB. Camilla has also been Head of Communications & Investor Relations at Securitas AB.

Pandox AB (publ) is required to publish this information under the Swedish Securities Market Act and/or Financial Instruments Trading Act. The information was submitted for publication on 21 September 2015 at 11:45 CEST.

About Pandox

Pandox is a leading owner of hotel properties in Northern Europe with a focus on sizeable hotels in key leisure and corporate destinations. Pandox’s hotel property portfolio comprises 104 hotels with approximately 22,000 hotel rooms across eight countries. Pandox’s business is organised into Property management, which comprises hotel properties leased on a long-term basis to market leading regional hotel operators and leading international hotel operators, and Operator activities, which comprises hotel operations executed by Pandox in its owner-occupied hotel properties. Pandox was founded in 1995 and the company’s B shares are, as of 18 June 2015, listed on Nasdaq Stockholm. www.pandox.se

This information was brought to you by Cision http://news.cision.com

Analysen zu Pandox AB (B)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Pandox AB (B) 192,40 0,84% Pandox AB (B)